Bactiguard Updates Trauma License Agreement with Zimmer Biomet
I'm PortAI, I can summarize articles.
Bactiguard Holding AB updates its trauma license agreement with Zimmer Biomet, focusing on the commercialization of the ZNN Bactiguard coated trauma nail system in Europe, MEA, and Japan. Bactiguard will receive royalties and a quarterly fixed fee, with no negative impact on its financial outlook for 2025 or strategic targets for 2030. Bactiguard regains global rights within trauma.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments